One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Issue Highlights
doi : 10.1016/S0360-3016(20)34511-9
Volume 109, ISSUE 1, PA13-A14, January 01, 2021
Single-fraction SBRT for Early Stage NSCLC-A Viable Option in “These Uncertain Times”?
Joseph K. Salama, Meredith E. Giuliani, Clifford G. Robinson, Megan E. Daly
doi : 10.1016/j.ijrobp.2020.08.031
Volume 109, ISSUE 1, P1-4, January 01, 2021
Lung Mass With Massive Hemoptysis: Treatment Without Tissue Diagnosis
Cam Nguyen, Nicholas Dietz
doi : 10.1016/j.ijrobp.2019.09.027
Volume 109, ISSUE 1, P5-6, January 01, 2021
Team-Based Approach
Meng Xu-Welliver
doi : 10.1016/j.ijrobp.2019.11.412
Volume 109, ISSUE 1, P7, January 01, 2021
Radiation is not the Ideal Solution
Shankar Siva, Daniel P. Steinfort
doi : 10.1016/j.ijrobp.2019.11.409
Volume 109, ISSUE 1, P7-8, January 01, 2021
Urgent, Urgent, Emergency: Treatment Without Tissue
Lauren Boreta
doi : 10.1016/j.ijrobp.2020.05.047
Volume 109, ISSUE 1, P8-9, January 01, 2021
Research-Driven Radiation Oncology: A Narrative on the Ongoing Legacy of Henry S. Kaplan
Eli J. Glatstein, MD, C. Norman Coleman, MD, David A. Pistenmaa, MD, PhD, Richard T. Hoppe, MD, ... Eric Bernhard, PhD
doi : 10.1016/j.ijrobp.2020.10.008
Volume 109, ISSUE 1, P10-14, January 01, 2021
Trends in Financial Relationships Between Industry and Radiation Oncologists Versus Other Physicians in the United States from 2014 to 2018
Deborah C. Marshall, Elizabeth S. Tarras, Kenneth Rosenzweig, Sue S. Yom, ... Susan Chimonas
doi : 10.1016/j.ijrobp.2020.08.043
Volume 109, ISSUE 1, P15-25, January 01, 2021
Increasing Nonresearch-Related Industry Funding in Radiation Oncology: Cause for Concern?
Trevor J. Royce, Gaorav P. Gupta, Bhisham S. Chera
doi : 10.1016/j.ijrobp.2020.09.003
Volume 109, ISSUE 1, P26-28, January 01, 2021
Informed Consent in Radiation Oncology
Stanley I. Gutiontov, Daniel W. Golden, Susan McCloskey, Dean Shumway, ... Reshma Jagsi
doi : 10.1016/j.ijrobp.2020.08.064
Volume 109, ISSUE 1, P29-35, January 01, 2021
SCAROP Letter to Academic Chairs: Racial Justice and Health Equity
Louis Potters, SCAROP Board
doi : 10.1016/j.ijrobp.2020.07.2314
Volume 109, ISSUE 1, P36-37, January 01, 2021
Responses to the 2018 and 2019 “One Big Discovery” Question: ASTRO Membership’s Opinions on the Most Important Research Question Facing Radiation Oncology…Where Are We Headed?
Michael M. Dominello, Tim Sanders, Mitchell Anscher, John Bayouth, ... James B. Yu
doi : 10.1016/j.ijrobp.2020.08.032
Volume 109, ISSUE 1, P38-40, January 01, 2021
RO Model: The Work Continues to Get it Right
Thomas J. Eichler
doi : 10.1016/j.ijrobp.2020.10.007
Volume 109, ISSUE 1, P41-43, January 01, 2021
The Role of Circulating Tumor Cells in Breast Cancer and Implications for Radiation Treatment Decisions
Chelain R. Goodman, Corey W. Speers
doi : 10.1016/j.ijrobp.2020.08.039
Volume 109, ISSUE 1, P44-59, January 01, 2021
Biophysical Characterization of the Leukemic Bone Marrow Vasculature Reveals Benefits of Neoadjuvant Low-Dose Radiation Therapy
Jamison Brooks, Bijender Kumar, Darren M. Zuro, Jonathan D. Raybuck, ... Susanta K. Hui
doi : 10.1016/j.ijrobp.2020.08.037
Volume 109, ISSUE 1, P60-72, January 01, 2021
Cell Killing and Chromosome Aberrations by Ionizing Radiations: Brother, Can You Paradigm?
Joel S. Bedford, J. Martin Brown
doi : 10.1016/j.ijrobp.2020.08.041
Volume 109, ISSUE 1, P73-75, January 01, 2021
Normal Tissue Response of Combined Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy
Matthias Sammer, Annique C. Dombrowsky, Jannis Schauer, Kateryna Oleksenko, ... Thomas E. Schmid
doi : 10.1016/j.ijrobp.2020.08.027
Volume 109, ISSUE 1, P76-83, January 01, 2021
Proton Radiotherapy to Preserve Fertility and Endocrine Function: A Translational Investigation
Jeffrey P. Gross, So-Youn Kim, Vinai Gondi, Mark Pankuch, ... Teresa K. Woodruff
doi : 10.1016/j.ijrobp.2020.07.2320
Volume 109, ISSUE 1, P84-94, January 01, 2021
Single High-Dose Radiation Enhances Dendritic Cell Homing and T Cell Priming by Promoting Reactive Oxygen Species-Induced Cytoskeletal Reorganization
Ziqi Zhou, Jing Zhao, Ke Hu, Xiaorong Hou, ... Linsheng Zhan
doi : 10.1016/j.ijrobp.2020.07.2321
Volume 109, ISSUE 1, P95-108, January 01, 2021
Brain Necrosis in Adult Patients After Proton Therapy: Is There Evidence for Dependency on Linear Energy Transfer?
Andrzej Niemierko, Jan Schuemann, Maximilian Niyazi, Drosoula Giantsoudi, ... Harald Paganetti
doi : 10.1016/j.ijrobp.2020.08.058
Volume 109, ISSUE 1, P109-119, January 01, 2021
Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study
Wang-Zhong Li, Shu-Hui Lv, Guo-Ying Liu, Hu Liang, ... Yan-Qun Xiang
doi : 10.1016/j.ijrobp.2020.08.045
Volume 109, ISSUE 1, P120-130, January 01, 2021
Locoregional Radiation Therapy for De Novo Metastatic Nasopharyngeal Cancer: One Size Fits All?
Lachlan McDowell, Danny Rischin, Anne W.M. Lee
doi : 10.1016/j.ijrobp.2020.10.001
Volume 109, ISSUE 1, P131-133, January 01, 2021
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu-Hui Chen, Raymond H. Mak, ... Jonathan D. Schoenfeld
doi : 10.1016/j.ijrobp.2020.08.018
Volume 109, ISSUE 1, P134-144, January 01, 2021
Radiation Therapy–Induced Changes of the Nasopharyngeal Commensal Microbiome in Nasopharyngeal Carcinoma Patients
Tingting Huang, Justine W. Debelius, Alexander Ploner, Xiling Xiao, ... Weimin Ye
doi : 10.1016/j.ijrobp.2020.08.054
Volume 109, ISSUE 1, P145-150, January 01, 2021
Topical Betamethasone Valerate As a Prophylactic Agent to Prevent Acute Radiation Dermatitis in Head and Neck Malignancies: A Randomized, Open-Label, Phase 3 Trial
Abhilash Menon, Shyama Sudha Prem, Rashmi Kumari
doi : 10.1016/j.ijrobp.2020.08.040
Volume 109, ISSUE 1, P151-160, January 01, 2021
Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study
Anders S. Vittrup, Kari Tanderup, S?ren M. Bentzen, Nina B.K. Jensen, ... Kathrin Kirchheiner
doi : 10.1016/j.ijrobp.2020.08.044
Volume 109, ISSUE 1, P161-173, January 01, 2021
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
William A. Hall, Eric Paulson, Brian J. Davis, Daniel E. Spratt, ... Colleen A.F. Lawton
doi : 10.1016/j.ijrobp.2020.08.034
Volume 109, ISSUE 1, P174-185, January 01, 2021
Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines
Christopher J. Anker, Jadranka Dragovic, Joseph M. Herman, Nancy A. Bianchi, ... Salma K. Jabbour
doi : 10.1016/j.ijrobp.2020.08.050
Volume 109, ISSUE 1, P186-200, January 01, 2021
Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704
Danielle S. Bitterman, Kathryn A. Winter, Theodore S. Hong, Charles S. Fuchs, ... Christopher H. Crane
doi : 10.1016/j.ijrobp.2020.08.042
Volume 109, ISSUE 1, P201-211, January 01, 2021
Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease
William C. Jackson, Ming Tang, Christopher Maurino, Mishal Mendiratta-Lala, ... Theodore S. Lawrence
doi : 10.1016/j.ijrobp.2020.08.046
Volume 109, ISSUE 1, P212-219, January 01, 2021
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration
Yolanda D. Tseng, Bradford S. Hoppe, Katerina Dedeckova, Chirayu G. Patel, ... John P. Plastaras
doi : 10.1016/j.ijrobp.2020.08.055
Volume 109, ISSUE 1, P220-230, January 01, 2021
Analysis of Radiation Dose/Volume Effect Relationship for Anorectal Morbidity in Children Treated for Pelvic Malignancies
Edouard Romano, Raphaël Simon, Véronique Minard-Colin, Valentine Martin, ... Cyrus Chargari
doi : 10.1016/j.ijrobp.2020.08.033
Volume 109, ISSUE 1, P231-241, January 01, 2021
Adaptive Proton Therapy for Pediatric Patients: Improving the Quality of the Delivered Plan With On-Treatment MRI
Sahaja Acharya, Chuang Wang, Sophia Quesada, Melissa A. Gargone, ... Chia-ho Hua
doi : 10.1016/j.ijrobp.2020.08.036
Volume 109, ISSUE 1, P242-251, January 01, 2021
Adjuvant Radiation Therapy Versus Surveillance After Surgical Resection of Atypical Meningiomas
Grace Lee, Nayan Lamba, Andrzej Niemierko, Daniel W. Kim, ... Helen A. Shih
doi : 10.1016/j.ijrobp.2020.08.015
Volume 109, ISSUE 1, P252-266, January 01, 2021
Safety Margins for the Delineation of the Left Anterior Descending Artery in Patients Treated for Breast Cancer
Eliot Nicolas, Nadjoua Khalifa, Cyril Laporte, Sabrina Bouhroum, Youlia Kirova
doi : 10.1016/j.ijrobp.2020.08.051
Volume 109, ISSUE 1, P267-272, January 01, 2021
Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates
Martin C. Tom, Sarah M.C. Sittenfeld, Chirag Shah, Kristine Bauer-Nilsen, ... Frank Vicini
doi : 10.1016/j.ijrobp.2020.07.2624
Volume 109, ISSUE 1, P273-280, January 01, 2021
Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation Sensitivity
Nafisha Lalani, K. David Voduc, Rachel B. Jimenez, Nathalie Levasseur, ... Alan Nichol
doi : 10.1016/j.ijrobp.2020.08.038
Volume 109, ISSUE 1, P281-287, January 01, 2021
Conformal Avoidance of Normal Organs at Risk by Perfusion-Modulated Dose Sculpting in Tumor Single-Dose Radiation Therapy
Carlo Greco, Richard Kolesnick, Zvi Fuks
doi : 10.1016/j.ijrobp.2020.08.017
Volume 109, ISSUE 1, P288-297, January 01, 2021
In Regard to Kang et al
Yuxiao Alice Wang, Kathrine S. Rallis
doi : 10.1016/j.ijrobp.2020.08.053
Volume 109, ISSUE 1, P298-299, January 01, 2021
In Reply to Wang and Rallis
Stella Kang, Amanda Caissie, Zahra Kassam, Paris-Ann Ingledew, ... Meredith Giuliani
doi : 10.1016/j.ijrobp.2020.08.052
Volume 109, ISSUE 1, P299-300, January 01, 2021
In Regard to Poppe et al
Brandon A. Dyer, Meghan R. Flanagan, Hakim K. Said, Janice Kim, ... L. Christine Fang
doi : 10.1016/j.ijrobp.2020.09.014
Volume 109, ISSUE 1, P300-301, January 01, 2021
In Reply to Dyer et al
Matthew M. Poppe, Atif J. Khan
doi : 10.1016/j.ijrobp.2020.09.013
Volume 109, ISSUE 1, P301-302, January 01, 2021
Erratum to: Sperduto PW, Mesko S, Li J, et al. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. Int J Radiat Oncol Biol Phys 2020:107(2);334-343.
doi : 10.1016/j.ijrobp.2020.09.057
Volume 109, ISSUE 1, P303, January 01, 2021
